SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-159935
Filing Date
2024-06-12
Accepted
2024-06-12 16:05:56
Documents
13
Period of Report
2024-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d843919d8k.htm   iXBRL 8-K 25445
  Complete submission text file 0001193125-24-159935.txt   151560

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vera-20240607.xsd EX-101.SCH 2836
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20240607_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20240607_pre.xml EX-101.PRE 11698
16 EXTRACTED XBRL INSTANCE DOCUMENT d843919d8k_htm.xml XML 3783
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 241038420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)